Pharmaceutical Consulting

Market Assessment

Our Market Assessment service delivers comprehensive market intelligence for pharmaceutical companies evaluating new opportunities. We combine epidemiological data, treatment landscape analysis, and competitive intelligence to provide accurate market sizing and forecasting across 190+ markets.

Key Benefits

How our market assessment service delivers value to your organization.

Accurate Market Sizing

Patient population-based market sizing with epidemiological models and treatment rate projections.

10-Year Forecasting

Revenue forecasts incorporating pipeline impact, generic entry, and market dynamics over a 10-year horizon.

Competitive Positioning

Detailed analysis of current and future competitors including market share, pricing, and differentiation opportunities.

White Space Mapping

Identify underserved patient segments and treatment gaps where new therapies can capture significant share.

What You Get

Comprehensive deliverables that provide actionable intelligence for your team.

Comprehensive market sizing report with patient population models
10-year revenue forecast with scenario analysis
Competitive landscape map with current and pipeline products
Pricing benchmark analysis across markets
Treatment algorithm and prescribing pattern analysis
Market entry strategy recommendations

Our Process

A structured methodology that delivers results in four phases.

01

Epidemiology

Build patient population models using epidemiological data and treatment rate assumptions.

02

Landscape Analysis

Map the current treatment landscape including approved therapies, prescribing patterns, and market shares.

03

Forecasting

Project market evolution incorporating pipeline products, generic entry, and pricing trends.

04

Strategy

Deliver actionable recommendations on market entry, positioning, and pricing strategy.

Frequently Asked Questions

What markets do you cover in your assessments?

We cover 190+ markets globally, including all major pharmaceutical markets (US, EU5, Japan, China, India) and emerging markets.

How far out do your forecasts project?

Our standard forecasts cover a 10-year horizon with annual projections, incorporating pipeline impact and market dynamics.

Can you assess markets for rare diseases?

Yes, we have specialized epidemiological models for rare diseases and orphan drug markets, including patient registry analysis.

Ready to Get Started?

Connect with our team to discuss how our market assessment service can support your goals.

Schedule a Consultation